Medpace Holdings Inc stock is traded at $653.38, with a volume of 6,706. It is down -0.09% in the last 24 hours and up +5.64% over the past month. Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
Previous Close:
$653.94
Open:
$653.94
24h Volume:
6,706
Relative Volume:
0.03
Market Cap:
$18.28B
Revenue:
$2.68B
Net Income/Loss:
$460.40M
P/E Ratio:
41.10
EPS:
$15.90
Net Cash Flow:
$711.00M
1W Performance:
-2.91%
1M Performance:
+5.64%
6M Performance:
+57.34%
1Y Performance:
+10.72%
1-Day Range:
$646.85$654.83
1-Week Range:
$644.77$671.92
52-Week Range:
$373.00$693.97
Medpace Holdings Inc Stock (MEDP) Company Profile
Name
Medpace Holdings IncSector
HealthcareIndustry
Diagnostics & ResearchPhone
(513) 579-9911Address
5375 MEDPACE WAY, CINCINNATI, OH, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS